The QualityStocks Daily Stock List
- Protagenic Therapeutics, Inc. (PTIX)
- Armata Pharmaceuticals (ARMP)
- TMC The Metals Company (TMC)
- Gatekeeper Systems (GKPRF)
- Ares Strategic Mining (ARSMF)
- NuCana (NCNA)
- Capricor Therapeutics (CAPR)
- Aris Mining (ARMN)
- Silo Pharma (SILO)
- Aditxt (ADTX)
- Aston Bay Holdings Ltd. (ATBHF)
- Canopy Growth Corp. (CGC)
Protagenic Therapeutics, Inc. (PTIX)
QualityStocks, MarketBeat, StreetInsider, SmarTrend Newsletters, Premium Stock Alerts, The Street, The Online Investor, Wall Street Resources, premiumstockalerts, InvestorPlace and Investing Futures reported earlier on Protagenic Therapeutics, Inc. (PTIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Protagenic Therapeutics Inc. (NASDAQ: PTIX) (FRA: MBPC) is a biopharmaceutical firm that is focused on discovering and developing therapies for the treatment of stress-related neuropsychiatric and mood disorders.
The firm has its headquarters in New York, the United States and was incorporated in 1994, on February 3rd by Hartoun Hartounian, David A. Lovejoy and Garo H. Armen. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United States.
The company has a team of biotech industry veterans and researchers focused on real-izing the potential of nature’s more highly-conserved neuropeptides. It develops new and naturally occurring human brain hormones for the treatment of mood disorders, which include anxiety, depression, post-traumatic stress disorder, and alcohol and drug addiction.
The enterprise’s pipeline is comprised of a synthetic form of TCAP (Teneurin Carboxy-terminal Associated Peptide) dubbed PT00114, which is an endogenous brain signal-ing peptide that has been designed to diminish overactive stress responses. This for-mulation has also shown pre-clinical effectiveness in an opioid withdrawal murine model known as the Saleens test. The enterprise has also developed a portfolio of new neuropeptides that are in different stages of pre-clinical evaluation and development for the treatment of mood disorders.
Protagenic Therapeutics, Inc. (PTIX), closed Monday's trading session at $11.1, up 266.3366%, on 97,394,284 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $2.35/$26.18.
Armata Pharmaceuticals (ARMP)
TradersPro, QualityStocks, FreeRealTime, StockMarketWatch and MarketBeat reported earlier on Armata Pharmaceuticals (ARMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Armata Pharmaceuticals Inc. (NYSE American: ARMP) (FRA: TG1N) is a biotechnology firm that is engaged in developing targeted bacteriophage therapeutics for treating antibiotic-resistant infections across the globe.
The firm has its headquarters in Marina del Rey, California and was incorporated in 2019, on May 9th. It operates as part of the pharmaceutical industry, under the health care sector, in the biotech and pharma sub-industry and mainly serves consumers in the state of California.
The company is focused on improving human health by developing new synthetic and natural bac-teriophage-based treatments using 2 platforms, namely peptides and synthetic phages, which will help prevent infectious ailments of the microbiome and treating multidrug-resistant bacterial infec-tions. It is party to a partnership agreement with Merck & Co. which entails the development of synthetic phage candidates that target infectious disease agents. The company was formed as a re-sult of a merger between AmpliPhi Biosciences and C3J Therapeutics.
The enterprise’s product pipeline comprises of AP-PA03, which is indicated for the treatment of pneumonia; AP-PA02, which has been developed to treat Pseudomonas aeruginosa and AP-SA02, which is indicated for the treatment of Staphylococcus aureus bacteremia. Each of the enterprise’s product candidates is a combination of several chosen phages, which target a particular disease-causing bacterial pathogen.
Armata Pharmaceuticals (ARMP), closed Monday's trading session at $2.37, up 75.5556%, on 13,182,929 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.8981/$3.4154.
TMC The Metals Company (TMC)
StocksEarning, StockEarnings, Schaeffer's, QualityStocks, MarketClub Analysis, MarketBeat, Premium Stock Alerts, Trades Of The Day, TradersPro, The Street, Investors Underground, InvestorPlace and InsiderTrades reported earlier on TMC The Metals Company (TMC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
TMC The Metals Company Inc. (NASDAQ: TMC) is an electric car battery metal firm that is en-gaged in the collection, processing and refining of polymetallic nodules.
The firm has its headquarters in Vancouver, Canada. Prior to its name change, the firm was known as Sustainable Opportunities Acquisition Corp. It operates as part of the metals and mining industry and serves consumers around the globe.
The company is focused on recovering metals from nodules in order to support demand from elec-tric car and battery production. Its collection of polymetallic nodules decreases the social and envi-ronmental impact of primary metal production, which it hopes could lead to a significant reduction of or total elimination of tailings.
The enterprise’s polymetallic nodules are obtained from the Clarion Clipperton Zone seafloor. This zone is found in the eastern part of the Pacific Ocean and is made up of abyssal plains and other formations. It occupies about 4500 miles and is known to not only contain a diversity and abun-dance of life but also manganese nodule resources. The enterprise holds commercial and explora-tion rights to 3 contract areas which host nodules that contain manganese, cobalt sulfate, copper and nickel sulfate. It produces these metals to power electric cars and store clean energy.
The company is well-positioned to not only grow but also bring in huge returns for its shareholders given the expectation that the demand for battery metals will continue to increase as more countries and people adopt the use of electric cars in order to reduce emissions. The adoption of electric ve-hicles will not only bring in additional revenue into the firm but also encourage more investments, which will boost its growth.
TMC The Metals Company (TMC), closed Monday's trading session at $4.45, up 22.2527%, on 24,111,766 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.721/$4.56.
Gatekeeper Systems (GKPRF)
InvestorPlace, QualityStocks and Trades Of The Day reported earlier on Gatekeeper Systems (GKPRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Gatekeeper Systems Inc. (OTC: GKPRF) (CVE: GSI) (FRA: 1GK) is a company focused on designing, manufacturing, marketing and selling video security solutions for extreme and mo-bile environments.
The firm has its headquarters in Abbotsford, Canada and was incorporated in 1997 by Doug-las A. Dyment. It operates as part of the security and protection services industry, under the industrials sector. The firm primarily serves consumers in Canada and the United States.
The enterprise’s offerings include the AI Dash Cam, an AI-based dash cam that offers driver status monitoring and advanced driver assistance systems; G4 Viewer, which revolutionizes video management for fleet monitoring; and CLARITY, an integrated video and passenger counting school bus operating platform. It also offers Automated Lane Enforcement, a video and data analytics solution that provides automatic enforcement of transit lane violations; in-terior and exterior cameras, and mobile data collectors; and wireless systems, such as access points, yard guards, mobile wireless modules, and mobile Wi-Fi systems. This is in addition to providing a health monitoring panel that measures the body temperature of individuals enter-ing a transportation vehicle or building; a school bus student protector solution that automati-cally enforces stop-arm violations; and an intelligent temperature sensing system. Further, the enterprise offers on-site system maintenance and repair, testing, troubleshooting, system in-stallation, training, and warranty support services. It serves the transit, school bus, police, am-bulance, taxi, and transport markets.
Gatekeeper Systems (GKPRF), closed Monday's trading session at $0.445, up 11.6127%, on 461,289 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.2128/$0.55.
Ares Strategic Mining (ARSMF)
We reported earlier on Ares Strategic Mining (ARSMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Ares Strategic Mining Inc. (OTCQX: ARSMF) (CNSX: ARS) (FRA: N8I1) is a junior natural resource mining firm that is focused on the identification and mining of fluor-spar properties.
The firm has its headquarters in Vancouver, Canada and was incorporated in 2009, on November 20th. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers around the globe.
The company is focused on exploiting, producing and supplying metspar and acidspar to the markets. Its projects include Liard Property, Lost Sheep and The Iron and Va-nadium Ridge. The company holds 100% interest in five properties located in Ontario, Canada; and in the Liard Fluorspar property, which includes over 55 mineral claims spanning across 55,000 acres in British Columbia; a well as the Lost Sheep Fluoride Mine, which comprises of 67 claims covering an area of approximately 1,447 acres lo-cated in western Utah, U.S. The Lost sheep mine is situated at the Spor Mountain area, Juab County, roughly 214 km south-west of Salt Lake City. It also holds 20% interest in the Vanadium Ridge property, which comprises of 20 mining claims that cover an area of about 5,200 acres located in the Kamloops, British Columbia. In addition to this, the company holds interest in the Campbell-Croster fluorspar project in Kentucky.
The enterprise, which possesses the only permitted fluorspar mine in the United States, is focused on acquiring new professional personnel and new strategic partners and building a global customer base. This may in turn help generate shareholder value.
Ares Strategic Mining (ARSMF), closed Monday's trading session at $0.166, up 10.6667%, on 2,106,847 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.088/$0.1717.
NuCana (NCNA)
QualityStocks, MarketClub Analysis, StockMarketWatch, MarketBeat, TraderPower, 360 Wall Street, Wealth Insider Alert, TradersPro, Schaeffer's, InvestorPlace, FreeRealTime and BUYINS.NET reported earlier on NuCana (NCNA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
NuCana PLC (NASDAQ: NCNA; FRA: NO4A) is a clinical-stage biotechnology firm which de-velops new treatments for treating breast, ovarian, pancreatic, biliary, hematology and colorectal cancers, which may better how chemotherapy treatments fight cancer.
The biopharmaceutical firm uses ProTide, its proprietary technology platform to manufacture can-cer medications that are better tolerated by patients as well as more effective. This technology was developed by the late Dr. Christopher McGuigan at Cardiff University.
NuCana PLC was founded on January 28, 1997 by Christopher B. Wood and Hugh S. Griffith, who is its current CEO. The firm, which was formerly known as NuCana BioMed Limited, changed its name in August 2017 before launching its IPO shortly after, in September. The compa-ny’s IPO generated $115 million. NuCana PLC serves customers in the United States as well as the U.K. and has its headquarters in Edinburgh, United Kingdom.
The company, which has a license agreement, collaboration and research with University College Cardiff Consultants Ltd and Cardiff University, has two primary ProTide technology candidates; NUC-3373 and Acelarin. The firm recently begun clinical trials for these candidates, where the former is in its Phase 1 clinical trial for the treatment of advanced solid tumors while the latter is in different phases of various clinical trials to examine the candidates’ efficacy in treating metastatic pancreatic cancer, biliary cancer, platinum-resistant ovarian cancer and biliary tract cancer. NuCana PLC is also conducting a phase 1 clinical trial for NUC-7738, its candidate designed to treat hema-tological tumors as well as advanced solid tumors.
NuCana (NCNA), closed Monday's trading session at $0.0482, up 10.0457%, on 181,238,020 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.0325/$10.79.
Capricor Therapeutics (CAPR)
StockMarketWatch, MarketClub Analysis, MarketBeat, QualityStocks, BUYINS.NET, TradersPro, TraderPower, StreetInsider, Prism MarketView, Wall Street Resources, Schaeffer's, InsiderTrades, OTCtipReporter, HotOTC, Marketbeat.com, Buzz Stocks, Jason Bond, Penny Pick Finders, PennyStockProphet, AllPennyStocks, PoliticsAndMyPortfolio, Profitable Trader Authority, smartOTC, StockOodles, Streetwise Reports, The Street, Wall Street Mover and PennyStockScholar reported earlier on Capricor Therapeutics (CAPR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Capricor Therapeutics Inc. (NASDAQ: CAPR) (FRA: 4LN2) is a clinical stage biotechnology firm that is engaged in developing transformative exosome and cell-based therapies for preventing and treating various rare ailments, like duchenne muscular dystrophy.
The firm has its headquarters in Beverly Hills, California and was incorporated in 2005. It operates in the healthcare sector, under the biotech and pharma sub-industry and serves consumers in Cana-da and the U.S.
The company is well positioned at the forefront of one of the biggest segments of the healthcare sectors in the US- cardiovascular disease, given that it’s a developer of innovative treatments. It is party to a collaboration agreement with Lonza Houston Inc. which entails developing its cell thera-py candidate dubbed CAP-1002, indicated for treating duchenne muscular dystrophy as well as other ailments.
The enterprise’s product pipeline is made up of a formulation currently in pre-clinical development dubbed CAP-2003, indicated for treating trauma-related conditions and injuries and an allogeneic cardiac-derive treatment dubbed CAP-1002, which is indicated for treating cardiac conditions like post myocardial infarction with cardiac dysfunction and heart failure and is also currently in phase 2 clinical trials testing its effectiveness in treating cytokine storms linked to the coronavirus. This formulation also concluded phase 2 clinical trials testing its effectiveness in treating late stage Du-chenne muscular dystrophy. In addition to this, the company is involved in developing 2 vaccine candidates for the potential prevention of the coronavirus, which are currently in the preclinical stage.
The firm’s CAP-1002 has shown tremendous potential in the management of Duchenne muscular dystrophy, which occurs in 1 in every 3600 live male births and affects about 200,000 young men and boys across the globe. The treatment’s success would not only address patients’ needs for a disease that has no cure but also bring in significant investments into the firm, which would en-hance growth.
Capricor Therapeutics (CAPR), closed Monday's trading session at $10.37, up 9.8517%, on 3,159,376 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $3.52/$23.4.
Aris Mining (ARMN)
Zacks and TradersPro reported earlier on Aris Mining (ARMN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Aris Mining Corp. (NYSE American: ARMN) (OTC: CLGDF) (TSE: ARIS) (FRA: ZP1) is a gold producer focused on acquiring, exploring for, developing, and operating gold properties in Canada, Guyana, and Colombia.
The firm has its headquarters in Vancouver, Canada and was incorporated in 1982. Prior to its name change in September 2022, the firm was known as GCM Mining Corp. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.
Aris Mining explores for gold as well as silver and copper deposits. It operates 2 mines with ex-pansions underway in Colombia, namely, Segovia and Marmato. The Segovia Operation is locat-ed in the Segovia-Remedios mining district in the department of Antioquia, Colombia, roughly 180km northeast of Medellin. The Segovia Operations comprises 4 active underground gold min-ing operations, which include Providencia, Carla, El Silencio, and Sandra K. It has over 11 titles with a total area of 5,335.58 hectares.
Its Marmato underground gold mine is located on the westside of the town of Marmato, in Marmato municipality of Caldas Department, in the Republic of Colombia, about 80km from Medellin and 200km northwest of the capital city of Bogota. Aris Mining also operates and owns 51% of the Soto Norte Project, which is advancing to develop a new underground gold, silver and copper mine. In Guyana, it is advancing the Toroparu gold/copper project.
Aris Mining (ARMN), closed Monday's trading session at $5.97, up 5.6637%, on 1,057,986 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $3.285/$6.07.
Silo Pharma (SILO)
QualityStocks, InvestorBrandNetwork, SmallCapRelations, MissionIR, SeriousTraders, Stocks to Buy Now, Tip.us, StocksToBuyNow, PsychedelicNewsWire, BioMedWire, SmallCapSociety, NetworkNewsWire, Fierce Analyst, Small Cap Firm, StockWireNews, StockStreetWire, Ross Givens, InvestorPlace, Jeff Bishop, MarketClub Analysis, ProTrader, OTCtipReporter, Penny Pick Finders, PennyStockScholar, Profitable Trader Authority, StockOnion, Tim Bohen, PennyStockProphet, MarketBeat, 360 Wall Street, Wealth Daily, Buzz Stocks and Premium Stock Alerts reported earlier on Silo Pharma (SILO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Silo Pharma (NASDAQ: SILO) a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, closed a public offering totaling approximately $2 million in gross proceeds. The offering included 3,333,338 shares of common stock or pre-funded warrants, along with Series A-1 and Series A-2 warrants, each allowing the purchase of up to 3,333,338 shares at $0.60 per share. The Series A-1 Warrants expire in five years, while the Series A-2 Warrants expire in eighteen months. H.C. Wainwright & Co. acted as the exclusive placement agent. Proceeds will be used for general working capital.
To view the full press release, visit https://ibn.fm/LeNuL
About Silo Pharma Inc.
Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug-delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting post-traumatic stress disorder (“PTSD”) and stress-induced anxiety disorders. SP-26 is a time-release, ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with universities and independent laboratories. For more information about the company, visit www.SiloPharma.com .
Silo Pharma (SILO), closed Monday's trading session at $0.504, up 4.2831%, on 320,923 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.473/$4.5.
Aditxt (ADTX)
QualityStocks, SmallCapRelations, SeriousTraders, InvestorBrandNetwork, Stocks to Buy Now, Tiny Gems, MissionIR, StocksToBuyNow, Tip.us, BioMedWire, NetworkNewsWire, SmallCapSociety, TinyGems, Premium Stock Alerts, BUYINS.NET, 360 Wall Street, Schaeffer's, MarketClub Analysis, FreeRealTime, MarketBeat, PennyStockProphet, PennyStockScholar, RedChip, PCG Advisory, OTCtipReporter, Penny Pick Finders, StockOnion, HotOTC, StreetInsider, Buzz Stocks, The Stock Dork, Timothy Sykes and Profitable Trader Authority reported earlier on Aditxt (ADTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Aditxt (NASDAQ: ADTX) , a social innovation platform advancing health innovations, announced its decision to terminate the Arrangement Agreement with Appili Therapeutics Inc., effective May 31, 2025. The agreement, first announced in April 2024, had been amended multiple times to address evolving conditions. Aditxt cited a lack of strategic alignment as the reason for discontinuing the deal, despite ongoing respect for Appili’s work. Management plans to formally notify Appili of the termination.
To view the full press release, visit https://ibn.fm/KSrpJ
About Aditxt Inc.
Aditxt is an innovation platform dedicated to accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners and shareholders collaboratively drives its mission to “Make Promising Innovations Possible Together.” The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress. Aditxt currently operates two programs focused on immune health and precision health. The company plans to introduce two additional programs dedicated to public health and women’s health. For these, Aditxt has entered into an arrangement agreement with Appili Therapeutics Inc. (TSX: APLI) (OTC: APLIF) , which focuses on infectious diseases, and a merger agreement with Evofem. Each program will be designed to function autonomously while collectively advancing Aditxt’s mission of discovering, developing and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. No assurance can be given that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close. For more information, please visit www.Aditxt.com .
Aditxt (ADTX), closed Monday's trading session at $1.75, up 5.4217%, on 111,553 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $1.51/$27200.
Aston Bay Holdings Ltd. (ATBHF)
QualityStocks, SmallCapRelations, SeriousTraders, MissionIR, MiningNewsWire, InvestorBrandNetwork, ESGWireNews, Stocks to Buy Now, Tip.us, StocksToBuyNow, SmallCapSociety, Rocks & Stocks, NetworkNewsWire and ESGWireNews Editor reported earlier on Aston Bay Holdings Ltd. (ATBHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Scrap copper exports effectively came to a sudden halt after Trump started a trade war with China and other trading partners around the world. China imports more than 50% of the scrap copper collected in the U.S., and the prohibitive tariffs between these major trading partners made it nearly impossible for this metal to change hands.
US dealers and their Chinese counterparts are frantically working the phones in order to complete deals and get scrap copper moving during the temporary truce that Trump says could end with high tariffs in case an appropriate deal isn’t agreed upon during the expected talks with China.
The disruptions seen in the market for scrap copper are a reflection of the chaos unleashed in various industries after the latest spate of the trade war was declared. The scramble within the market for scrap copper shows just how difficult it can be to remedy supply chain issues after the fact, and it isn’t a sure deal that relationships that existed before the turmoil will be rebuilt to the same degree during this truce or even after a permanent deal is struck.
Scrap yards in the U.S. were forced to sell the metal at steep discounts while processors in China scrambled to look for alternative suppliers of the scrap they badly needed for their operations. Given that China buys the bulk of the scrap copper originating in America, both sides suffered a great deal from the time “Liberation Day” tariffs were announced.
The copper market is widely viewed as the pulse of the global economy since it’s heavily used as an industrial metal. Given that newly mined copper has been declining in volume, scrap has been meeting approximately 33% of the annual demand for copper around the world. Copper is needed in the EV industry in addition to other electrical equipment and installations.
In 2024 America sold 600,000 tons of scrap copper to address the huge global demand. This quantity made the scrap metal from the U.S. to exceed the annual production capacity of several major mining operations around the world.
As a result of the tariffs, American scrap copper yards have failed to get sufficient alternative buyers of the metal, and this caused scrap metal prices to tumble immensely. Fastmarkets data shows dealers were compelled to offer 95 cents discounts on each pound of copper in comparison to the price at which copper futures are traded. This is the widest-ever difference in price.
What is happening in the market for scrap copper affects the trading of freshly mined copper, and enterprises like Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) are likely to keep a close eye on the evolving situation in order to adjust their projections and strategies accordingly.
NOTE TO INVESTORS: The latest news and updates relating to Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) are available in the company’s newsroom at https://ibn.fm/ATBHF
Aston Bay Holdings Ltd. (ATBHF), closed Monday's trading session at $0.03805, up 6.882%, on 10,000 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.03095/$0.107.
Canopy Growth Corp. (CGC)
InvestorPlace, Schaeffer's, The Street, QualityStocks, StocksEarning, StockEarnings, MarketClub Analysis, Trades Of The Day, MarketBeat, Daily Trade Alert, Kiplinger Today, The Online Investor, Wealth Insider Alert, Streetwise Reports, StreetInsider, CFN Media Group, Market Intelligence Center Alert, Investopedia, Zacks, Stock Up Featured, StreetAuthority Daily, Daily Profit, The Wealth Report, Early Bird, SmallCapVoice, Top Pros' Top Picks, CannabisNewsWire, StockMarketWatch, Wall Street Grand, Lebed.biz, SeriousTraders, INO Market Report, Profit Trends, Money Morning, BUYINS.NET, Louis Navellier, Cannabis Financial Network News, Jim Cramer, Inside Trading, Investors Underground, CNBC Breaking News, StocksToBuyNow, Outsider Club, Trading For Keeps, TradersPro, MarketClub, AllPennyStocks, Beat The Street, Wealth Daily, Cabot Wealth, VectorVest, Trading Concepts, Timothy Sykes, Tim Bohen, Profit Confidential, Technology Profits Daily, Insider Wealth Advice, Investment U, InvestmentHouse, Stock Gumshoe, Rick Saddler, Investors Alley, Raging Bull All Access, 24/7 Trader, Money and Markets and TheTradingReport reported earlier on Canopy Growth Corp. (CGC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
In a closely split 5-4 ruling, the U.S. Supreme Court recently sided with a commercial truck driver who sued three CBD firms under the federal RICO statute. The driver, Douglas Horn, claimed he was fired after a drug test came back positive for THC, despite using a CBD product that was labeled as THC-free.
At the center of the case was a legal debate over whether people can bring civil RICO claims to recover financial damages that result from a personal injury. Some courts had previously allowed such lawsuits to move forward, while others dismissed them on the grounds that RICO was not intended to cover harm tied to bodily injuries. The Supreme Court’s decision has clarified that if someone suffers economic losses—like losing a job or future earnings—because of a personal injury, they can still sue under RICO.
This ruling opens the door for more civil lawsuits under RICO against marijuana-related businesses. Legal experts expect attorneys may start using the case as a model to bring similar actions, especially where consumers believe they were misled by false advertising or inaccurate product labels.
Originally enacted in 1970 to combat organized crime, the RICO law allows individuals to sue if they suffer harm to their business or property due to a pattern of unlawful conduct carried out by an organization. That conduct can include fraud, like falsely labeling and shipping a product through the mail or over digital networks.
Horn had been using “Dixie X,” a CBD tincture he bought to help relieve pain from a car accident. It was advertised as free of THC. However, after testing positive for the substance during a surprise drug screening at work and refusing to enroll in a treatment program, he was let go. Later lab tests revealed that the product did contain THC.
Horn sued the companies behind the product in federal court in New York, accusing them of fraud and alleging they worked together as a RICO enterprise to distribute mislabeled goods. While the trial court initially dismissed his lawsuit, saying RICO doesn’t cover claims linked to personal injury, an appeals court disagreed—and now, so has the Supreme Court.
Justice Amy Coney Barrett, writing for the majority, stated that while physical injuries themselves aren’t covered under RICO, the financial consequences tied to them, such as being fired, are. This distinction could mean big changes for the marijuana industry, which may now face increased legal exposure, stricter oversight, and greater pressure to accurately label and market their products.
Marijuana industry companies like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) will have plenty to think about regarding the possible global ramifications of the U.S. Supreme Court ruling in this case.
Canopy Growth Corp. (CGC), closed Monday's trading session at $1.64, off by 1.2048%, on 5,861,346 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.77/$11.14.
The QualityStocks Company Corner
- D-Wave Quantum Inc. (NYSE: QBTS)
- Soligenix Inc. (NASDAQ: SNGX)
- Intelligent Bio Solutions Inc. (NASDAQ: INBS)
- Calidi Biotherapeutics Inc. (NYSE American: CLDI)
- NRx Pharmaceuticals, Inc (NRXP)
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)
- Nightfood Holdings Inc. (OTCQB: NGTF)
- FAVO Capital Inc. (OTC: FAVO)
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)
- Massimo Group (NASDAQ: MAMO)
- Nutriband Inc. (NASDAQ: NTRB)
- Vivakor Inc. (NASDAQ: VIVK)
D-Wave Quantum Inc. (NYSE: QBTS)
The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).
The GOP administration recently released another round of AI chip export restrictions against China to prevent it from acquiring advanced semiconductors from American chipmakers. This announcement came as Nvidia CEO Jensen Huang was unveiling the Blackwell architecture and a major AI partnership in Saudi Arabia. The U.S. Commerce Department has issued a warning against using American-made AI chips in Chinese models and condemned diversionary supply chain tactics that attempt to circumvent these restrictions. As the largest computer chip manufacturer globally, American chipmaker Nvidia has been riding high on the Artificial Intelligence (AI) craze. However, with the Santa Clara, California-based company drawing 13% of its revenue from the Chinese market, it risks losing a significant portion of its sales due to geopolitical volatility. With the trade war between the U.S. and China intensifying, the Trump administration risks adding further complications to the growing list of challenges Nvidia faces. As the U.S. expands chip export restrictions, companies like Nvidia risk losing access to China's massive AI market. This could slow their revenue growth, increase reliance on riskier emerging markets, and force them to cut back on research and development. Long term, it may weaken America's tech leadership and reshape the global semiconductor industry. Other technology companies like D-Wave Quantum Inc. (NYSE: QBTS) will be studying the new export restrictions as they could impact market segments that they may have had in their sights as they made their growth plans.
D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.
D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).
D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.
D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.
Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.
Advantage™ Quantum Computer
With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.
D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.
That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.
Leap Quantum Cloud Service
D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.
Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.
Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.
D-Wave Launch
D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.
From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.
Target Verticals
While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:
- Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
- Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
- Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.
Market Opportunity
The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.
Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.
D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.
D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.
Leadership Team
Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.
John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.
D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $13.15, up 7.3469%, on 14,068,362 volume. The average volume for the last 3 months is 54,992,337 and the stock's 52-week low/high is $0.7505/$13.44.
Recent News
- D-Wave Quantum Inc. (NYSE: QBTS) - Further US Chip Export Restrictions Pose More Challenges for Nvidia
- How AI Can Supercharge SMBs Around the World
- D-Wave Quantum Inc. (NYSE: QBTS) Reports Record First Quarter Revenue, Gross Profit and Cash Position
Soligenix Inc. (NASDAQ: SNGX)
The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).
Q1 milestones are representative of Soligenix's commitment to advance its pipeline of therapeutic candidates, focusing on areas with significant unmet medical needs.
The company noted positive interim results from the ongoing open-label, investigator-initiated study ("IIS") evaluating extended HyBryte(TM) treatment.
Soligenix announced the release of a publication describing the preclinical efficacy of CiVax(TM), a thermostabilized subunit vaccine against SARS-CoV-2.
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases, recently announced its financial results for the first quarter of 2025, alongside a summary of the company's latest accomplishments ( https://ibn.fm/OMQmM ). These milestones are representative of Soligenix's continued commitment to advance its pipeline of therapeutic candidates, focusing on areas with significant unmet medical needs.
Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.
The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.
With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.
The company is headquartered in Princeton, New Jersey.
Pipeline and Development Programs
Specialized BioTherapeutics
Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.
SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.
SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.
Public Health Solutions
The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.
The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.
The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.
Market Opportunity
Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.
SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.
In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.
Leadership Team
Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.
Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.
Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.
Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.
Investment Considerations
- Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
- The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
- Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
- The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
- Soligenix is led by an experienced management team with a strong track record of success.
Additional Resources
Soligenix Inc. (NASDAQ: SNGX), closed Monday's trading session at $1.88, up 1.0753%, on 348 volume. The average volume for the last 3 months is 160,859 and the stock's 52-week low/high is $1.68/$14.8299.
Recent News
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results
- BioMedNewsBreaks - Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial
- Study Links Higher Consumption of Ultra-Processed Foods to Heightened Psoriasis Risk
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
The QualityStocks Daily Newsletter would like to spotlight Intelligent Bio Solutions Inc. (NASDAQ: INBS).
Intelligent Bio Solutions (Nasdaq: INBS) , a medical technology company focused on rapid, non-invasive testing, successfully completed a full workforce drug screening for Barcaldine Regional Council in Queensland, Australia, using its Intelligent Fingerprinting Drug Screening System. Over 160 employees were tested and cleared within 90 minutes, significantly reducing operational disruption compared to traditional methods. The on-site, fingerprint-based solution enabled same-day results and supported immediate workforce return, highlighting INBS' growing presence in regional and remote testing markets.
To view the full article, visit https://ibn.fm/Abbvo
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings such as opiates, cocaine, methamphetamine, and cannabis. This innovative approach positions INBS to transform drug testing protocols, particularly in industries where safety and speed are mission critical.
The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers companies and organizations to screen more efficiently. INBS continues to drive adoption in international markets, with customers spanning construction, logistics, healthcare, government, and drug treatment sectors.
INBS’s mission is centered on delivering accessible, transformative solutions that improve lives and operational safety. As the company expands toward a planned U.S. market launch in 2025, it is also strengthening its intellectual property portfolio and localizing solutions for Spanish-speaking regions.
The company is headquartered in New York, New York.
Intelligent Fingerprinting Drug Screening System
Intelligent Bio Solutions’ flagship offering is the Intelligent Fingerprinting Drug Screening System, a portable, three-part solution that includes a fingerprint collection cartridge, a lateral flow-based DSR-Plus reader, and software for rapid drug screening. Designed to be used on-site, this system eliminates the complexities and hazards of urine and saliva tests, offering a clean, fast, and non-invasive alternative.
The system screens for a broad range of substances including opiates, methamphetamine, cocaine, cannabis, benzodiazepines, and more. Its cost advantage is significant — point-of-care fingerprint tests cost approximately $20, compared to $300 for typical urine or saliva testing. The platform includes over 1,000 DSR-Plus Readers installed across customer sites, supporting a base of more than 450 active customer accounts globally. In clinical studies, the system demonstrated 94.1% accuracy and 100% specificity, providing a credible foundation for future FDA approvals and market expansion.
In addition to drug screening, INBS is developing a proprietary biosensor platform designed to detect specific biomarkers from non-invasive samples such as sweat, saliva, and interstitial fluid. These additional applications remain under development.
Market Opportunity
Intelligent Bio Solutions operates at the intersection of workplace safety, public health, and diagnostic innovation. The company is targeting the drug screening products market, which is projected to reach $14.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.1%, according to Research and Markets.
In the U.S., substance abuse is a $400 billion issue, with more than 70% of individuals using illicit drugs or alcohol currently employed. This presents an urgent need for scalable, workplace-compatible screening technologies. Industries such as transportation, construction, mining, and healthcare are among the highest adopters of employee drug testing protocols, driven by regulatory requirements and safety imperatives.
INBS’s non-invasive solution is well-positioned to capitalize on trends toward less invasive, faster, and more convenient testing methods — potentially displacing legacy systems reliant on urine or saliva testing, which have longer turnaround times and greater administrative burdens.
Leadership Team
Harry Simeonidis, Chief Executive Officer, has over 25 years of experience across the healthcare, pharmaceutical, and life sciences industries. He previously served as General Manager for Surgery, Asia Pacific at GE Healthcare. Prior to that, he was President and CEO of GE Healthcare ANZ, where he led significant market share growth.
Spiro Sakiris, Chief Financial Officer, brings 34 years of expertise in accounting, taxation, IPO preparation, and capital raising. He is highly experienced with IFRS and U.S. GAAP applications in the life sciences sector and is a member of the Institute of Chartered Accountants of Australia & New Zealand.
Investment Considerations
- INBS offers a patented, non-invasive testing solution positioned to disrupt a global drug screening market projected to reach $14.9 billion by 2030.
- The company is revenue-generating, with 148% year-over-year growth in FY 2024 and 450+ active customer accounts.
- Its Intelligent Fingerprinting system provides rapid, on-site results with a lower cost and higher convenience compared to traditional methods.
- The Intelligent Fingerprinting Drug Screening System is already in commercial use internationally, and a U.S. product launch is planned for 2025, with FDA 510(k) clearance in process and new patent protections underway.
- INBS is led by a seasoned executive team with global healthcare and commercialization experience.
Additional Resources
Intelligent Bio Solutions Inc. (NASDAQ: INBS), closed Monday's trading session at $1.235, up 1.2295%, on 2,241 volume. The average volume for the last 3 months is 103,104 and the stock's 52-week low/high is $1/$3.
Recent News
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) - BioMedNewsBreaks - Intelligent Bio Solutions Inc. (Nasdaq: INBS) Expands Remote Workforce Testing with Fingerprint Drug Screening in Australia
- Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
- BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
Calidi Biotherapeutics Inc. (NYSE American: CLDI)
The QualityStocks Daily Newsletter would like to spotlight Calidi Biotherapeutics Inc. (NYSE American: CLDI).
Experienced leadership contributes to key performance indicators.
Dr. Eric Poma brings more than 30 years of experience to his new role as CLDI CEO.
His expertise will help the company develop and advance proprietary groundbreaking therapies.
Effective leadership is a cornerstone of organizational success, particularly in the dynamic and high-stakes realm of biotechnology. Recognizing the pivotal role of seasoned leadership, Calidi Biotherapeutics (NYSE American: CLDI) has announced the appointment of Eric Poma, PhD, as its new Chief Executive Officer and member of the board of directors ( https://ibn.fm/qMEu4 ). This strategic transition underscores Calidi's commitment to advancing its innovative cancer therapies under experienced guidance. Dr. Poma succeeds Allan Camaisa, who will continue to serve as a board member.
Calidi Biotherapeutics Inc. (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering proprietary technology that empowers the immune system to combat cancer. Calidi’s innovative, off-the-shelf cell-based platforms use allogeneic stem cells to deliver potent oncolytic viruses (OVs) across multiple oncology indications, including high-grade glioma (brain cancers) and solid tumors. In addition, Calidi has presented a breakthrough systemic technology, RTNova, which utilizes an exteracellular enveloped virotherapy. RTNova is pre-clinical and has been extremely well-received by market analysts and large-cap biopharma – opening the door for potential collaboration.
These cell-based platforms are engineered to protect, amplify, and enhance the efficacy of oncolytic viruses, resulting in improved patient safety and potentially advancing treatment outcomes for metastatic disease. By employing a dual approach that combines OV delivery with immune activation, Calidi’s therapies aim to not only treat but potentially prevent the spread of metastatic cancers.
The company’s development pipeline leverages this technology to address pressing needs in cancers such as glioblastoma (brain cancer), metastatic melanoma, triple-negative breast cancer, head & neck cancer, and lung cancer. Calidi’s approach has shown early signals of efficacy and safety, establishing it as a distinctive player in the growing OV market, which is projected to increase significantly in value over the next decade.
Calidi is headquartered in San Diego, California.
Products
Calidi’s product pipeline includes advanced cell-based platforms targeting a variety of oncology indications, each designed to harness the power of oncolytic virotherapy for improved cancer treatment outcomes.
- NeuroNova (CLD-101): A platform designed for treating high-grade gliomas (HGG), NeuroNova employs neuronal stem cells combined with an engineered adenovirus (CRAD-s-Pk7) to selectively target glioma cells. After a successful Phase 1 safety study in newly diagnosed HGG, NeuroNova has now progressed into Phase 1/1b trials for recurrent cases. FDA clearance for a Phase 1b/2 trial at Northwestern University was received in September 2024, with patient enrollment expected to begin in Q1 2025. This trial will utilize multiple-dose intracerebral administration to maximize safety and efficacy in newly diagnosed HGG patients.
- SuperNova (CLD-201): Built on Calidi’s foundational technology, SuperNova utilizes an engineered Vaccinia virus (CAL1) delivered via allogeneic adipose-derived mesenchymal stem cells to target advanced solid tumors, including head & neck, triple-negative breast cancer, and soft tissue sarcomas. Early studies with autologous stem cells demonstrated both safety and promising efficacy, and Calidi plans to begin a Phase 1 trial with multiple dose regimens for SuperNova in the coming months.
- RTNova (CLD-400): Calidi’s systemic delivery platform for lung and metastatic cancers, RTNova employs an extracellular enveloped virotherapy (envRT-01) technology for intravenous (IV) administration, simplifying the treatment process and expanding its potential applications. Currently in preclinical stages, RTNova focuses on demonstrating efficacy and safety through systemic administration. A clinical trial targeting metastatic lung cancer is anticipated for Q2 2026, using a single-arm monotherapy with dose escalation. Calidi has partnered with SIGA Technologies (NASDAQ: SIGA) to support the development of this program.
Market Opportunity
The global oncology drugs market was valued at $201.75 billion in 2023 and is projected to grow to $518.25 billion by 2032, with a CAGR of 11.3%. The oncolytic virotherapy market in particular is growing rapidly, driven by increasing approval rates and significant unmet needs.
The market for OV treatments is expected to expand from one approved product generating $150 million in the U.S. in 2021 to 6-8 approved therapies generating $2.4 billion by 2030. As a leader in OV technology, Calidi is well-positioned to address these high-demand areas in oncology.
Alongside global trends, the American Cancer Society projects nearly two million new cancer diagnoses in the U.S. in 2024, reflecting a 28% increase since 2010. This underscores the urgent need for novel therapies that not only treat disease progression but also enhance patient quality of life, reinforcing the demand for Calidi’s innovative approaches.
Management Team
Allan Camaisa, CEO, Chairman, and co-founder, is a seasoned leader with extensive experience in scaling businesses to successful exits. Mr. Camaisa previously led High Technology Solutions, growing it from two employees to over 500 with $50 million in revenue. He also served as CEO of Parallel6 Inc. and is a U.S. Naval Academy graduate with further studies at Harvard Business School.
Antonio Santidrian, Ph.D., Chief Scientific Officer, leads all research and development initiatives at Calidi and is the coinventor of the company’s CLD-201 (Supernova) and CLD-400 (RTNova) platforms. Since joining Calidi in 2015, he has applied his 20+ years of expertise in academia and biotech, focusing on anti-cancer translational research, to drive the company’s innovative drug pipeline. Before Calidi, Dr. Santidrian led translational studies at The Scripps Research Institute, advancing treatments for breast cancer metastasis, and contributed to the development of ACADRA for chronic lymphocytic leukemia (CLL) at the University of Barcelona, Spain.
Boris Minev, M.D., President of Medical and Scientific Affairs, is a renowned physician-scientist with expertise in Immuno-Oncology, stem cell biology, and oncolytic viruses. Previously, Dr. Minev served as Director of Immunotherapy and Translational Oncology at Genelux Corporation and remains an adjunct professor at the Moores UCSD Cancer Center. His background includes research at the National Cancer Institute.
Andrew Jackson, CFO, has held executive finance roles with experience in biotech and clinical-stage companies, including Eterna Therapeutics and Ra Medical Systems. Mr. Jackson holds an MSBA in Finance from San Diego State University and a BSB in Accounting from the University of Minnesota.
Additional Resources
Calidi Biotherapeutics Inc. (NYSE American: CLDI), closed Monday's trading session at $0.418, up 1.9512%, on 40 volume. The average volume for the last 3 months is 210,738 and the stock's 52-week low/high is $0.35/$4.9.
Recent News
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO
- BioMedNewsBreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances Redtail Virotherapy Platform and Reduces Q1 Losses
- BioMedNewsBreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment
NRx Pharmaceuticals Inc. (NASDAQ: NRXP)
The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).
Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of Republican lawmakers advocating for the therapeutic use of psychedelics to treat PTSD, depression, and suicidality among veterans—a movement recently spotlighted by The Wall Street Journal. After undergoing ibogaine and DMT therapy in Mexico in 2018, Luttrell described the experience as transformative, helping him confront trauma and save his marriage. Now in Congress, he's pushing for science-based, medically supervised access to Schedule I drugs like ibogaine, psilocybin, and MDMA. Joined by fellow veterans in office, including Rep. Dan Crenshaw (R-Texas) and Rep. Jack Bergman (R-Mich.), Luttrell is helping lead legislative efforts to fund clinical trials through the VA and Pentagon, despite resistance from some conservatives and recent regulatory setbacks like the FDA's rejection of an MDMA therapy from Lykos Therapeutics. Amid this shift, NRx Pharmaceuticals (NASDAQ: NRXP) and its subsidiary HOPE Therapeutics are emerging as leaders in veteran-focused psychedelic innovation. HOPE is developing ketamine-based treatments for acute suicidality and major depression and is building a nationwide network of interventional psychiatry clinics. The company recently signed a $7.8 million debt financing agreement to support clinic acquisitions and has announced partnerships with Kadima and Dura Medical to accelerate its rollout. With more than 6,400 veteran suicide deaths reported in 2022, advocates argue these alternative therapies could offer urgent relief where conventional treatments have failed. As Republican support grows and the Trump-aligned VA signals openness to new approaches, companies like NRx are poised to play a central role in advancing the next generation of mental health care for veterans.
For more information, visit the company's website at https://ir.nrxpharma.com.
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).
With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.
By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.
NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.
NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.
Product Portfolio
NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:
- NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
- NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
- Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.
NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.
HOPE Therapeutics
HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.
The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.
With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.
Market Opportunity
The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.
Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.
Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.
Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.
Leadership Team
Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.
Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.
Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.
Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.
Investment Considerations
- NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
- The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
- NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
- HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
- The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
- NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.
Additional Resources
NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Monday's trading session at $2.44, off by 0.4081633%, on 1,776 volume. The average volume for the last 3 months is 219,460 and the stock's 52-week low/high is $1.1/$6.01.
Recent News
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
- PsychedelicNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup
- BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Secures $7.8M to Launch Clinic Rollup Strategy
SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)
The QualityStocks Daily Newsletter would like to spotlight SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).
SolarBank (NASDAQ: SUUN) (CSE: SUNN) posted fiscal Q3 results for the period ended March 31, 2025, showing year-to-date revenue of C$29.1 million versus C$50.4 million a year earlier, reflecting a shift toward long-term asset ownership over short-term EPC sales. The company reported a net loss of C$9 million compared to net income of C$5.5 million last year, driven by higher costs and reduced EPC activity. SolarBank highlighted a 395% increase in assets to C$194 million following the Solar Flow-Through Funds acquisition and secured a mandate letter with CIM Group for up to US$100 million in project financing for a 97 MW solar portfolio in the U.S., reinforcing its strategy to grow its independent power producer platform.
To view the full press release, visit https://ibn.fm/bWlJj
SolarBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. SolarBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.
With a vision to provide scalable and reliable clean energy solutions, SolarBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.
Driven by a mission to create a greener future, SolarBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.
SolarBank has offices in Toronto, Ontario and New York.
Projects
SolarBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, SolarBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of SolarBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.
In Canada, SolarBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.
The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.
Market Opportunity
SolarBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.
The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.
SolarBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance SolarBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, SolarBank stands as a key player in driving the renewable energy transition.
Leadership Team
Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of SolarBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.
Sam Sun, MBA, is the Chief Financial Officer of SolarBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.
Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.
Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive SolarBank’s growth.
Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by SolarBank, enhancing its asset portfolio and growth prospects.
Forward Looking Statements
This report contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, “forward-looking statements”) that relate to the Company’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. In particular and without limitation, this report contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this report should not be unduly relied upon. These statements speak only as of the date of this report.
Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.
Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-Looking Statements” and “Risk Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.
The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them, or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this report are expressly qualified in their entirety by this cautionary statement.
Additional Resources
SolarBank Corp. (NASDAQ: SUUN), closed Monday's trading session at $1.82, off by 0.5464481%, on 238 volume. The average volume for the last 3 months is 135,513 and the stock's 52-week low/high is $1.7901/$6.87.
Recent News
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - GreenEnergyBreaks - SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing
- GreenEnergyBreaks - SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) CEO Highlights Vertical Integration and $184M Asset Base on GotStocks Podcast
- US House Points Guns on Clean Energy, Climate Policies in Budget Proposals
Nightfood Holdings Inc. (OTCQB: NGTF)
The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).
Nightfood Holdings Inc. (OTCQB: NGTF) is a hospitality technology and asset acquisition company revolutionizing hotel operations through AI-driven service robotics and strategic property acquisitions. By integrating advanced automation solutions with high-value hospitality assets, NGTF is setting a new standard for operational efficiency, cost reduction, and labor optimization in the hospitality industry.
With a focus on Robotics-as-a-Service (RaaS) and hotel ownership, NGTF is uniquely positioned at the intersection of technology and real estate, creating scalable, revenue-generating solutions that drive the widespread adoption of automation in the hospitality sector.
Operations
Nightfood Holdings is focused on two core business areas:
- Hotel Acquisitions & Operations – NGTF is acquiring a portfolio of independent hospitality properties, spanning various market segments from midscale to luxury. These hotels serve as real-world testbeds for automation technologies, allowing NGTF to refine its RaaS solutions before deploying them at scale.
- Robotics-as-a-Service (RaaS) for Hospitality – NGTF provides subscription-based, AI-driven robotic automation, designed to optimize hotel operations. By deploying standardized automation solutions, NGTF helps hotels reduce costs, improve labor efficiency, and enhance guest experiences.
Through this fully integrated model, NGTF ensures that its robotics solutions are tested, optimized, and proven profitable before expanding to third-party hotel operators.
Market Opportunity
The demand for automation in hospitality is accelerating, driven by labor shortages, rising costs, and increased competition. NGTF is positioned to capitalize on this shift through its combined hotel ownership and RaaS strategy.
- Total Addressable Market (TAM): The global service robotics market is projected to reach approximately $107.75 billion by 2030, driven by widespread adoption across industries including hospitality, according to Research and Markets.
- Serviceable Available Market (SAM): The global smart hospitality market, which includes AI and automation technologies for hotels, is projected to reach $186.10 billion by 2032, according to SNS Insider.
- Competitive Positioning: NGTF’s unique real estate + automation model allows it to implement cost-saving robotics solutions in real-world environments before expanding adoption across the industry.
Industry Impact: The Future of Smart Hotels
NGTF is at the forefront of next-generation hospitality automation, transforming how hotels operate. By combining AI-powered service robotics with real estate acquisitions, NGTF is pioneering the transition to smart, highly efficient hotel environments.
Hotels acquired by NGTF serve as testing grounds for robotics deployment, allowing the company to continuously refine its automation solutions. The biggest industry benefits include:
- Cost Savings for Hotel Operators – Reducing labor costs and improving operational efficiency.
- Scalability & Standardization – Offering a streamlined, subscription-based RaaS model for seamless automation adoption.
- Industry Leadership in Hotel Robotics – Driving the transformation of hospitality with AI-powered automation solutions.
Future Vision & Growth Strategy
Over the next three to five years, NGTF is committed to scaling both its hotel portfolio and RaaS adoption. By refining and optimizing its automation technologies in its own properties, NGTF will continue deploying RaaS to third-party hotel operators, positioning itself as a leader in next-generation hospitality automation.
Through strategic acquisitions and AI-driven solutions, NGTF is defining the future of smart hotels—delivering cost-efficient, scalable automation that reshapes the hospitality landscape.
Team Expertise as a Strategic Advantage
In addition to technology and real estate, NGTF’s most powerful asset is its team. The company’s leadership and operating partners bring deep expertise in both hospitality and food service, having collectively developed over 50 properties, managed more than 130 hotels, and supported more than 6,000 quick-service restaurants.
This wealth of experience enables NGTF to execute its automation and acquisition strategy with operational discipline, industry insight, and scale—further strengthening its position in next-generation hospitality.
Investment Considerations
- Dual Growth Strategy – NGTF combines hotel acquisitions with AI-powered automation, creating an integrated model that maximizes operational efficiency and revenue potential.
- Expanding Robotics-as-a-Service (RaaS) – Subscription-based robotic automation solutions designed to reduce operational costs and address labor shortages for hotel operators.
- Strategic Hotel Acquisitions – Acquiring a variety of hospitality assets, from midscale to luxury, to serve as testing grounds for AI-driven automation and to drive profitability.
- Proven Market Demand – Rising labor costs and increasing adoption of service robotics are fueling demand for automation in hospitality, positioning NGTF as an early leader in the sector.
- Scalable & Revenue-Generating Model – By owning hotels and offering RaaS to third-party operators, NGTF is building a diversified, high-growth business model.
Additional Resources
Nightfood Holdings Inc. (OTCQB: NGTF), closed Monday's trading session at $0.0325, up 41.3043%, on 223,034 volume. The average volume for the last 3 months is 744,000 and the stock's 52-week low/high is $0.0053/$0.0571.
Recent News
- Nightfood Holdings Inc. (OTCQB: NGTF) - TechMediaBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney's Cotino Project
- TechMediaBreaks - Nightfood Holdings Inc. (NGTF) Positioning to Lead Future of Hospitality
- InvestorNewsBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Appoints New CEO and President to Lead AI-Driven Hospitality Expansion
FAVO Capital Inc. (OTC: FAVO)
The QualityStocks Daily Newsletter would like to spotlight FAVO Capital Inc. (NASDAQ: FAVO).
FAVO Capital Inc. (OTC: FAVO) is redefining the private credit and alternative lending industry through a strategic redevelopment of its operations and offerings. With a focus on leveraging financial technology and a client-centric approach, FAVO Capital empowers small to medium-sized businesses with fast, flexible, and reliable access to capital, bridging the gap left by traditional financial institutions.
Empowering Businesses, Redefining Private Credit
As part of its strategy to uplist to Nasdaq, FAVO Capital is enhancing its technology platform, operational scalability, and market positioning to meet higher regulatory standards and attract institutional investors. Headquartered in Fort Lauderdale, Florida, FAVO employs over 120 professionals across five global offices, delivering sustainable growth and value for clients and shareholders alike.
Products and Services
- Proprietary Lending Platform and Mobile App (In Development): FAVO Capital is in the early stages of developing an advanced digital platform designed to enhance client engagement and streamline funding processes. This platform will eventually allow businesses to apply for funding products, track progress, and manage repayment efficiencies. A complementary mobile app is also being planned to provide real-time insights and tailored recommendations, laying the groundwork for an improved borrower experience.
- Fintech-Driven Lending Solutions: FAVO Capital is exploring proprietary and third-party technology tools, including advanced analytics and algorithms, to enhance decision-making speed and reliability in the lending process.
- Flexible Financing Options: FAVO specializes in structuring customized capital solutions tailored to the diverse needs of small business owners, offering scalable and adaptable products that evolve with changing market conditions.
Market Opportunity
The private credit market is experiencing exponential growth as traditional banks reduce their focus on small business lending. According to industry reports, the global private credit market is projected to surpass $1.5 trillion by 2025, driven by increasing demand for alternative financing options.
FAVO Capital is uniquely positioned to capture market share within this booming sector by leveraging fintech innovation to meet the needs of underserved small businesses. With a focus on efficiency, speed, and client satisfaction, FAVO addresses critical gaps in the financial ecosystem while building a platform for long-term growth.
Recent Highlights
- Fintech Innovation: Initial investments in app development and analytics lay the groundwork for future operational efficiency and improved borrower experience.
- Operational Scale: A global footprint with over 120 employees combines the agility of a local lender with the reach of an international financial institution.
- Proven Growth: FAVO’s technology-driven approach has enabled consistent expansion, solidifying its reputation as a trusted partner for small businesses.
Leadership Team
Vincent Napolitano is a Founder and CEO of FAVO Capital Inc. With over two decades of experience in finance and business development, Vincent has been instrumental in building FAVO Capital into a trusted partner for businesses seeking innovative financial strategies. Prior to founding FAVO Capital, Vincent spent 25 years on Wall Street, holding key positions at prominent firms and developing expertise in structuring complex financial deals. He also served as Chief Investment Officer for multiple special purpose vehicles (SPVs), acquiring private stock in pre-IPO unicorn companies such as Facebook and Twitter.
Shaun Quin is a Founding Member and President of FAVO Capital Inc., overseeing the company’s mission to deliver innovative and efficient private credit solutions to small and medium-sized businesses. With over 20 years of global experience as a partner, investor, and director, Shaun brings a strategic and customer-focused approach to his leadership. His expertise in fostering collaboration, building high-performance cultures, and empowering businesses has positioned FAVO Capital as a trusted leader in private lending.
Vaughan Korte, CFO, brings over 15 years of global financial expertise to his role with FAVO Capital Inc. His track record includes managing financial operations for Adidas across 60 countries with budgets exceeding $500 million. Vaughan’s leadership ensures FAVO Capital remains financially resilient, aligning financial strategy with organizational goals and fostering shareholder value.
Glen Steward, Chief Strategy Officer, is a seasoned entrepreneur with over 28 years of experience in the investment and trading industries. He drives FAVO Capital’s strategic initiatives, ensuring the company remains competitive and agile in a rapidly evolving market. Glen has held directorships and board memberships across Mauritius, South Africa, and the United States. His strategic acumen has been pivotal in integrating the FAVO Group of Companies into FAVO Capital Inc., fueling growth and market leadership.
Advisory Board
Bilal Adam, Accounting & Financial Counsel, is a financial expert with over 20 years of experience, including roles as CEO of Stewards Investment Capital. His insights into bespoke investment solutions, including fixed income, equity, and digital assets, support FAVO Capital’s innovative approach to private credit.
Honorable Earnest Hart, Corporate Governance Counsel, brings decades of legal and governance experience, having served as a New York Supreme Court Judge and COO at Columbia University Medical Center. His guidance ensures FAVO Capital maintains robust corporate governance standards.
Rocco Trotta, Business Leadership and Scalability Counsel, is the co-founder of LiRo-Hill and has decades of experience scaling businesses. His expertise in organizational efficiency and talent development strengthens FAVO Capital’s ability to attract excellence across all aspects of the business.
As FAVO Capital redevelops its operations and prepares for an uplisting to Nasdaq, the company is laying the foundation to redefine private credit with emerging fintech solutions and exceptional leadership. Learn more by visiting investors.favocap.com.
Investment Considerations
- Early-Stage Technology Development: Laying the groundwork for proprietary platforms and scalable digital tools.
- Significant Market Opportunity: The private credit market is projected to exceed $1.5 trillion by 2025, providing exponential growth potential.
- Scalable Business Model: Automated processes and data-driven decision-making enable rapid scaling with minimal overhead.
- Customer-Centric Approach: FAVO’s focus on small businesses and flexible financing solutions addresses critical gaps in the financial ecosystem.
- Experienced Leadership: A forward-thinking executive team ensures strategic growth and innovation.
Additional Resources
FAVO Capital Inc. (OTC: FAVO), closed Monday's trading session at $1.05, even for the day, on 200 volume. The average volume for the last 3 months is 140 and the stock's 52-week low/high is $0.162/$1.45.
Recent News
- FAVO Capital Inc. (OTC: FAVO) - TechMediaBreaks - FAVO Capital Inc. (FAVO) to Present Growth Strategy at D. Boral Capital Inaugural Global Conference
- InvestorNewsBreaks - FAVO Capital Inc. (FAVO) Converts Super Voting Shares to Support Nasdaq Uplisting Plans
- InvestorNewsBreaks - FAVO Capital Inc. (FAVO) Secures $8 Million Series A Investment to Fuel Growth and Nasdaq Uplisting Plans
Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)
The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.
The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.
The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.
PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.
The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.
Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.
Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.
Waterberg Project
Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.
The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.
The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.
South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.
Market Opportunity
According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.
Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.
A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.
Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.
An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.
Management Team
Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.
Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.
Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.
Additional Resources
Platinum Group Metals Ltd. (NYSE American: PLG), closed Monday's trading session at $1.15, up 2.6786%, on 4,166 volume. The average volume for the last 3 months is 583,378 and the stock's 52-week low/high is $0.99/$2.27.
Recent News
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself for Growth Amid Palladium Market Dynamics
- Nickel Miners in Indonesia Decry Royalty Rate Increase, Warn of Possible Layoffs
- RockBreaks - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Plans $1 Million Private Placement with Major Shareholder HCI
Massimo Group (NASDAQ: MAMO)
The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).
Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.
Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.
The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.
Product Portfolio
Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.
- Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
- Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
- Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.
By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.
Market Opportunity
The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.
The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.
With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.
Leadership Team
David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.
Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.
Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.
Investment Considerations
- Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
- The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
- Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
- During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
- Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
- Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.
Additional Resources
Massimo Group (NASDAQ: MAMO), closed Monday's trading session at $2.2706, up 2.2747%, on 7,053 volume. The average volume for the last 3 months is 7,638 and the stock's 52-week low/high is $2.1601/$4.6599.
Recent News
- Massimo Group (NASDAQ: MAMO) - The Slate Truck Could Usher in New Era for EVs
- Massimo Group (NASDAQ: MAMO) Rides the Wave of Growing Powersports
- Massimo Group (NASDAQ: MAMO): Digital Pivot Targets Nationwide Revenue Growth
Nutriband Inc. (NASDAQ: NTRB)
The QualityStocks Daily Newsletter would like to spotlight Nutriband Inc. (NASDAQ: NTRB).
Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.
AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.
The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.
Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.
In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.
In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.
The company is headquartered in Orlando, Florida.
Products
Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.
Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.
In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex®, a widely used aversive agent, to enhance the deterrent profile of its patch formulation.
AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.
Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.
Market Opportunity
Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.
The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.
Management Team
Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.
Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.
Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.
Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.
Investment Considerations
- Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients.
- AVERSA technology can be incorporated into any transdermal patch.
- The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
- Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch.
- In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support AVERSA Fentanyl’s pathway to market.
Additional Resources
Nutriband Inc. (NASDAQ: NTRB), closed Monday's trading session at $5.71, up 1.6014%, on 21,245 volume. The average volume for the last 3 months is 47,923 and the stock's 52-week low/high is $3.7223/$11.78.
Recent News
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
- Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch
- Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
Vivakor Inc. (NASDAQ: VIVK)
The QualityStocks Daily Newsletter would like to spotlight Vivakor Inc. (NASDAQ: VIVK).
Vivakor Inc. (NASDAQ: VIVK) is a vertically integrated energy infrastructure and environmental services company, focused on the transportation, storage, reuse, and remediation of oilfield fluids and waste. The company operates a large-scale oilfield trucking fleet serving key U.S. energy regions, enabling end-to-end solutions for the handling of crude oil and produced water. Through long-term contracts and strategic asset positioning, Vivakor delivers critical services to upstream energy operators seeking efficient and environmentally responsible operations.
Vivakor’s vision is to become a leader in sustainable energy logistics and remediation by combining innovative infrastructure with environmentally conscious practices. The company’s integrated model allows it to optimize the flow and treatment of petroleum-based materials across the value chain. By owning and operating both the logistics and remediation components, Vivakor is well-positioned to support an evolving energy ecosystem.
The company’s mission is to develop, acquire, accumulate, and operate assets, properties, and technologies that enhance efficiency and sustainability within the energy sector. This includes the ongoing development of oilfield waste remediation facilities, which will facilitate the recovery and reuse of petroleum byproducts.
The company is headquartered in Dallas, Texas.
Operations
Vivakor’s operations span crude oil and produced water gathering, transportation, storage, and remediation. Leveraging a large-scale oilfield trucking fleet, the company delivers mission-critical logistics services under long-term agreements with energy producers. Its integrated facility assets support efficient fluid movement and storage while aligning with evolving environmental standards.
The company is actively developing oilfield waste remediation capabilities designed to recycle and safely dispose of petroleum byproducts. These facilities will process contaminated materials and convert them into reusable resources, supporting more sustainable field operations. In 2023, Vivakor expanded its infrastructure through the acquisitions of Silver Fuels Delhi and White Claw Colorado, strengthening its midstream footprint and operational reach across key U.S. basins.
Vivakor delivered triple-digit revenue growth in 2023, reflecting increased demand for its integrated services and the impact of strategic asset expansion. This momentum positions the company for further scale as environmental regulations and logistics needs continue to evolve across the energy sector.
Market Opportunity
Vivakor operates at the intersection of energy logistics and environmental remediation—two sectors undergoing transformation amid rising regulatory pressure and sustainability goals. According to Allied Market Research, the global oilfield services market was valued at $268.1 billion in 2022 and is projected to reach $346.45 billion by 2032, growing at a CAGR of 2.6% during the forecast period. As producers seek efficiency and environmental compliance, demand for integrated logistics and remediation services is expected to grow.
Additionally, the global produced water treatment market is forecast to reach $12.2 billion by 2028, up from $8.6 billion in 2023, driven by increased recycling efforts and stricter disposal regulations. Vivakor’s remediation facilities, once operational, will directly serve this need by offering oilfield clients sustainable waste processing and reuse options.
By addressing both logistical and environmental challenges in energy production, Vivakor is strategically positioned to capture value across multiple growth verticals in a dynamic market landscape.
Leadership Team
James Ballengee, President & Chief Executive Officer, is an energy entrepreneur and operator with over 15 years of experience in oilfield logistics, midstream infrastructure, and energy asset development. Prior to leading Vivakor, he served as Managing Partner at Silver Fuels Delhi and White Claw Colorado, both of which were acquired by Vivakor in 2023. He has held executive roles in multiple energy companies where he focused on developing vertically integrated logistics and remediation systems. Ballengee specializes in contract structuring, capital deployment, and building operationally efficient service platforms across the energy sector.
Tyler Nelson, Chief Financial Officer, is a licensed CPA with extensive experience in public company financial leadership, SEC reporting, and audit readiness. Prior to joining Vivakor, he served as Corporate Controller at two Nasdaq-listed companies and held audit roles at prominent regional accounting firms. His background spans oil & gas, renewables, and technology, where he has led successful finance transformations, SOX compliance rollouts, and investor reporting improvements. At Vivakor, Nelson oversees all financial operations, capital strategy, and compliance functions.
Investment Considerations
- Vivakor achieved substantial revenue growth in 2023, driven by expanded logistics operations and newly integrated midstream assets.
- The company operates a large-scale oilfield trucking fleet under long-term contracts, providing recurring revenue and service continuity.
- Its remediation facilities, once operational, will address a produced water treatment market forecast to reach $12.2 billion by 2028.
- Recent acquisitions have enhanced Vivakor’s infrastructure footprint and extended its service reach across key U.S. energy basins.
- The company’s integrated model aligns with industry trends favoring sustainability, compliance, and full-cycle fluid management.
Additional Resources
Vivakor Inc. (NASDAQ: VIVK), closed Monday's trading session at $0.7852, up 0.9254498%, on 9,434 volume. The average volume for the last 3 months is 49,561 and the stock's 52-week low/high is $0.5504/$3.45.
Recent News
- Vivakor Inc. (NASDAQ: VIVK) - Vivakor Inc. (NASDAQ: VIVK) Is 'One to Watch'
- Vivakor Provides 2024 Review and 2025 Outlook
- Vivakor Reports Fourth Quarter Year-Over-Year 201% Revenue Growth to $41.7 Million
The QualityStocks Numbers Report
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
- Adageis - InvestorNewsBreaks – Adageis’ Fintech Platform Drives Smarter, More Profitable Healthcare
- Aditxt Inc. (NASDAQ: ADTX) - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics
- Amesite Inc. (NASDAQ: AMST) - Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - Appia Announces That Stephen Burega is Leaving the Company
- Annovis Bio Inc. (NYSE: ANVS) - InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Appoints Hui Liu as Director of Biostatistics
- Astiva Health - UnitedHealth Records Lower Revenue as Medical Advantage Use Grows
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Arizona Metals Intersects 34.8 m @ 11.3 g/t AuEq in Kay2 Zone
- Astrotech Corp. (NASDAQ: ASTC) - 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Scrap Copper to Start Moving After Trump Declared Truce with China
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) - Battery Mineral Resources Announces Receipt of Second Payment and Closing of Previously Announced Royalty Financing with Electric Royalties
- Bebuzee Inc. (OTC: BBUZ) - InvestorNewsBreaks - Bebuzee Inc. (BBUZ) Revolutionizes Content Monetization with Creator-First Super App
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - BioMedNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain in 2024, Driven by Loan-to-Equity Conversion
- Bravo Multinational Inc. (OTC: BRVO) - InvestorNewsBreaks - Bravo Multinational Inc. (OTC: BRVO) Unveils First Charitable Mobile Service
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology 2024 Financial Results Report: Total Assets Surge by 53%
- Btab Ecommerce Group Inc. (OTC: BBTT) - Integrated Wellness Acquisition Corp. and Btab Ecommerce Group, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
- Brera Holdings PLC (NASDAQ: BREA) - Brera Holdings PLC (NASDAQ: BREA) to Pilot 'PLAY LEAP' Digital Fan Engagement Platform with Juve Stabia
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - Canada Nickel Secures US$20 Million Bridge Loan Facilitated by BT Capital and Provides Corporate Update
- CISO Global, Inc. (NASDAQ: CISO) - CISO Global brings AI to $50 Billion Insurance Market with Cyber Assurance Group Strategic Partnership to Deliver Innovative Cyber Technology and Insurance Solutions
- Clene Inc. (NASDAQ: CLNN) - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Reports Q1 Results, Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer
- Correlate Energy Corp. (OTCQB: CIPI) - GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
- Coyuchi Inc. - InvestorNewsBreaks – Coyuchi Inc. Pushing Organic Textile Market Forward Through Its Circular Initiatives
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. Eyes Increase in Stock Price
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Taps Thermo Fisher for Phase 3 and Commercial Production of CYB003
- DarioHealth Corp. (NASDAQ: DRIO) - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
- Diamond Lake Minerals Inc. (OTC: DLMI) - Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
- Data443 Risk Mitigation Inc. (OTC: ATDS) - Data443 Completes Operational Expense Rationalization
- D-Wave Quantum Inc. (NYSE: QBTS) - Further US Chip Export Restrictions Pose More Challenges for Nvidia
- ECGI Holdings Inc. (OTC: ECGI) - InvestorNewsBreaks - ECGI Holdings Inc. (ECGI) Confident Its New Allon Apparel Line Will Set 'New Benchmark' in Luxury Market
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Eloro Resources Announces Closing of $2.5 Million Non-Brokered Private Placement
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Engages Norda Stelo for Gap Analysis at Lac Pelletier, Eyes Near-Term Production
- Energy and Water Development Corp. (OTCQB: EAWD) - Data Officers and the Crucial Role They Play in ESG Accountability
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Posts $26 Million Q1 Loss, Increases 2025 Uranium Production Forecast
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - EverGen Infrastructure Reports Q4 & Year End 2024 Results
- ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Draws Additional Experience to Board Amid Ramp-up to Production
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - Exro Technologies Responds to Market Activity
- FingerMotion Inc. (NASDAQ: FNGR) - TechMediaBreaks - FingerMotion Inc. (NASDAQ: FNGR) Expands to Indonesia with AI Insurance Platform Through Mach Wireless Deal
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - InvestorNewsBreaks - First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - MiningNewsBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Upsizes Private Placement to C$1.5 Million on Strong Investor Demand
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Posts $26 Million Q1 Loss, Increases 2025 Uranium Production Forecast
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) Announces Proposed $1M Non-Brokered Private Placement
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) - InvestorNewsBreaks - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Completes Geophysical Survey at CLK Uranium Property in Athabasca Basin
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), BuilderX Partner to Integrate Advanced 3D Perception Technology into Heavy Machinery
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Freight Technologies Inc. (NASDAQ: FRGT) - TechMediaBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Moves to Advance Digital Asset Strategy
- Gaxos.ai Inc. (NASDAQ: GXAI) - AINewsBreaks - Gaxos.ai Inc. (NASDAQ: GXAI) Approved for AWS Marketplace Listing, Expanding Reach for Game Developer Platform
- GEMXX Corp. (OTC: GEMZ) - Baker Hughes Says Oil, Gas Rigs in the US Have Reduced Significantly
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) - InvestorNewsBreaks - Global Compliance Applications Corp. (CSE: APP) (OTC: FUAPF) (FSE: 2FA), EMTRI Corp. Scale Services in California's Booming Cannabis Market
- GivBux Inc. (OTC: GBUX) - InvestorNewsBreaks - GivBux Inc. (OTC: GBUX) to Appear on Cheddar TV's 'Go Fund Yourself' for Live Investor Pitch
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc. (NASDAQ: GMGI) CEO to Present at the Upcoming 17th Annual LD Micro Main Event
- SportLync Inc. - SportLync Outlines 2025 Roadmap, with Expanded Sports Offerings and Enhanced User Experiences
- Greenwave Technology Solutions Inc. (NASDAQ: GWAV) - TechMediaBreaks - Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Sees Margin Growth as Scrap Steel Prices Surge
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) to Participate at Upcoming LD Micro Main Event XVII
- HeartBeam Inc. (NASDAQ: BEAT) - BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
- HealthLynked Corp. (OTCQB: HLYK) - BioMedNewsBreaks - HealthLynked Corp. (HLYK) Launches Upgrade to Empower Patients, Drive Better Outcomes
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Featured in Latest Episode of MarketGems Podcast
- Horizon Fintex | Upstream - InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Launches Rebrand Featuring New Name, New Look, New Packaging
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp. (BLQC) Completes 'Key Steps' in Long-Term Vision to Strengthen Position as an Innovator in Healthcare Solutions
- Kairos Pharma Ltd. (NYSE American: KAPA) - BioMedNewsBreaks - Kairos Pharma Ltd. (NYSE American: KAPA) to Participate in D. Boral Capital Global Conference on May 14
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Grows Q1 Revenue 29% and Narrows Losses Ahead of Investor Showcase
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Announces Entry into Common Stock Purchase Agreements with Gross Proceeds of $750K
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Present 'Important' Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer's Disease Conference
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - Why Trump May Be Unlikely to Stop Public EV Charger Construction
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc.'s (NASDAQ: LTRY) Sports.com Achieves Major Milestone in Its Global Expansion
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Record Transaction Growth, No. 1 Ranking on Lightning Terminal
- Massimo Group (NASDAQ: MAMO) - The Slate Truck Could Usher in New Era for EVs
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Targets Gold Growth with Fox Complex Expansion, Reports Q1 Results
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- NanoViricides Inc. (NYSE American: NNVC) - InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials
- Newton Golf Company Inc. (NASDAQ: NWTG) - TinyGemsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Reports 246% Revenue Growth and Expanding Tour Adoption in Q1
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - BioMedNewsBreaks - NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds
- Nightfood Holdings Inc. (OTCQB: NGTF) - TechMediaBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney's Cotino Project
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Poised to Capitalize on Copper Demand Surge Driven by AI-Powered Data Centers
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Oragenics Inc. (NYSE American: OGEN) - InvestorNewsBreaks - Oragenics Inc. (NYSE American: OGEN) Secures Australian Approval to Launch Phase II Concussion Trial
- Mullen Automotive Inc. (NASDAQ: MULN) - Foxtron Announces Project to Develop, Make EVs for Mitsubishi
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Leads the Charge in AI-Driven Marketing with Proprietary Platform
- PaxMedica Inc. (NASDAQ: PXMD) - Kids with Autism are Less Prone to Severe Injuries Compared to Those with ADHD
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself for Growth Amid Palladium Market Dynamics
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 17% Working Interest Increase in Its Core Heavy Oil Properties
- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) - InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Dosing in Key Toxicity Studies for MS Drug Candidate
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - IEA Review: 2024 Electricity Demand Surge Boosted Both Fossil Fuels and Renewables
- Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) - InvestorNewsBreaks - Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Highlights Exploration Strategy and Growth Potential on The Bell2Bell Podcast
- G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) - InvestorNewsBreaks - G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Delivers Free Cash Flow and $24.4M Q1 Profit, Advances Oko West
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc.'s (NASDAQ: NITO) (FSE: 80W) Subsidiary Enters LOI with Ethiopian Federal Agency to Support Transition to Sustainable Farming Practices
- Software Effective Solutions Corp. (OTC: SFWJ) - InvestorNewsBreaks - Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) Cancels and Swaps Over 88M Shares to Reduce Outstanding Share Count
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - GreenEnergyBreaks - SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants
- SUIC Worldwide Holdings Ltd. (OTC: SUIC) - InvestorNewsBreaks - SUIC Worldwide Holdings Ltd. (SUIC) Names Seasoned Veteran as Newest Director
- SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) to Attend Two Upcoming Industry Events
- SOBRsafe Inc. (NASDAQ: SOBR) - InvestorNewsBreaks - SOBRsafe Inc. (NASDAQ: SOBR) Appoints Kris Pederson to Board, Adds Scientific Advisor to Advance Tech and Governance
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group, Inc. (NYSE American: SBEV) Revises Terms for Western Son Vodka Acquisition
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (NYSE American: SLI) Advances Southwest Arkansas Lithium Project with $225M DOE Grant, Regulatory Milestones
- Starco Brands Inc. (OTCQB: STCB) - InvestorNewsBreaks - Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils Market's Most Efficient, Powerful Inboard Electric Motor System
- SenesTech Inc. (NASDAQ: SNES) - InvestorNewsBreaks - SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - TechMediaBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Expands Into Africa with Focus on Cybersecurity for Government and Enterprise Clients
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - InvestorNewsBreaks - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Names Seasoned Veteran as New Director
- Thumzup Media Corp. (NASDAQ: TZUP) - UN Study Suggests AI Could Boost Human Development
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) - InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
- Torr Metals Inc. (TSX.V: TMET) - Gold Ticks Up as Dollar Loses Steam
- TransCode Therapeutics Inc. (NASDAQ: RNAZ) - InvestorNewsBreaks - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances RNA Cancer Therapy as 15 Patients Dosed in Phase 1a Trial
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - MiningNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Secures Debentureholder Approval for Debt Settlement and Extension
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shareholders Approve Key Proposals at Extraordinary General Meeting
- Uranium Energy Corp. (NYSE American: UEC) - BillionDollarBreaks - Uranium Energy Corp. (NYSE American: UEC) Partners with Radiant on U.S. Nuclear Microreactor Fuel Supply
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
- Datavault AI Inc. (NASDAQ: DVLT) - InvestorNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) Reaffirms $50M 2026 Revenue Target Ahead of CSI Acquisition Close
- Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) - InvestorNewsBreaks - Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Reports Record Revenue and Raises Dividend in Strong Q1 2025
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
- Adageis - InvestorNewsBreaks – Adageis’ Fintech Platform Drives Smarter, More Profitable Healthcare
- Aditxt Inc. (NASDAQ: ADTX) - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics
- Amesite Inc. (NASDAQ: AMST) - Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - Appia Announces That Stephen Burega is Leaving the Company
- Annovis Bio Inc. (NYSE: ANVS) - InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Appoints Hui Liu as Director of Biostatistics
- Astiva Health - UnitedHealth Records Lower Revenue as Medical Advantage Use Grows
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Arizona Metals Intersects 34.8 m @ 11.3 g/t AuEq in Kay2 Zone
- Astrotech Corp. (NASDAQ: ASTC) - 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Scrap Copper to Start Moving After Trump Declared Truce with China
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) - Battery Mineral Resources Announces Receipt of Second Payment and Closing of Previously Announced Royalty Financing with Electric Royalties
- Bebuzee Inc. (OTC: BBUZ) - InvestorNewsBreaks - Bebuzee Inc. (BBUZ) Revolutionizes Content Monetization with Creator-First Super App
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - BioMedNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain in 2024, Driven by Loan-to-Equity Conversion
- Bravo Multinational Inc. (OTC: BRVO) - InvestorNewsBreaks - Bravo Multinational Inc. (OTC: BRVO) Unveils First Charitable Mobile Service
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology 2024 Financial Results Report: Total Assets Surge by 53%
- Btab Ecommerce Group Inc. (OTC: BBTT) - Integrated Wellness Acquisition Corp. and Btab Ecommerce Group, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
- Brera Holdings PLC (NASDAQ: BREA) - Brera Holdings PLC (NASDAQ: BREA) to Pilot 'PLAY LEAP' Digital Fan Engagement Platform with Juve Stabia
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - Canada Nickel Secures US$20 Million Bridge Loan Facilitated by BT Capital and Provides Corporate Update
- CISO Global, Inc. (NASDAQ: CISO) - CISO Global brings AI to $50 Billion Insurance Market with Cyber Assurance Group Strategic Partnership to Deliver Innovative Cyber Technology and Insurance Solutions
- Clene Inc. (NASDAQ: CLNN) - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Reports Q1 Results, Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer
- Correlate Energy Corp. (OTCQB: CIPI) - GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
- Coyuchi Inc. - InvestorNewsBreaks – Coyuchi Inc. Pushing Organic Textile Market Forward Through Its Circular Initiatives
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. Eyes Increase in Stock Price
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Taps Thermo Fisher for Phase 3 and Commercial Production of CYB003
- DarioHealth Corp. (NASDAQ: DRIO) - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
- Diamond Lake Minerals Inc. (OTC: DLMI) - Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
- Data443 Risk Mitigation Inc. (OTC: ATDS) - Data443 Completes Operational Expense Rationalization
- D-Wave Quantum Inc. (NYSE: QBTS) - Further US Chip Export Restrictions Pose More Challenges for Nvidia
- ECGI Holdings Inc. (OTC: ECGI) - InvestorNewsBreaks - ECGI Holdings Inc. (ECGI) Confident Its New Allon Apparel Line Will Set 'New Benchmark' in Luxury Market
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Eloro Resources Announces Closing of $2.5 Million Non-Brokered Private Placement
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Engages Norda Stelo for Gap Analysis at Lac Pelletier, Eyes Near-Term Production
- Energy and Water Development Corp. (OTCQB: EAWD) - Data Officers and the Crucial Role They Play in ESG Accountability
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Posts $26 Million Q1 Loss, Increases 2025 Uranium Production Forecast
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - EverGen Infrastructure Reports Q4 & Year End 2024 Results
- ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Draws Additional Experience to Board Amid Ramp-up to Production
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - Exro Technologies Responds to Market Activity
- FingerMotion Inc. (NASDAQ: FNGR) - TechMediaBreaks - FingerMotion Inc. (NASDAQ: FNGR) Expands to Indonesia with AI Insurance Platform Through Mach Wireless Deal
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - InvestorNewsBreaks - First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - MiningNewsBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Upsizes Private Placement to C$1.5 Million on Strong Investor Demand
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Posts $26 Million Q1 Loss, Increases 2025 Uranium Production Forecast
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) Announces Proposed $1M Non-Brokered Private Placement
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) - InvestorNewsBreaks - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Completes Geophysical Survey at CLK Uranium Property in Athabasca Basin
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), BuilderX Partner to Integrate Advanced 3D Perception Technology into Heavy Machinery
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Freight Technologies Inc. (NASDAQ: FRGT) - TechMediaBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Moves to Advance Digital Asset Strategy
- Gaxos.ai Inc. (NASDAQ: GXAI) - AINewsBreaks - Gaxos.ai Inc. (NASDAQ: GXAI) Approved for AWS Marketplace Listing, Expanding Reach for Game Developer Platform
- GEMXX Corp. (OTC: GEMZ) - Baker Hughes Says Oil, Gas Rigs in the US Have Reduced Significantly
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) - InvestorNewsBreaks - Global Compliance Applications Corp. (CSE: APP) (OTC: FUAPF) (FSE: 2FA), EMTRI Corp. Scale Services in California's Booming Cannabis Market
- GivBux Inc. (OTC: GBUX) - InvestorNewsBreaks - GivBux Inc. (OTC: GBUX) to Appear on Cheddar TV's 'Go Fund Yourself' for Live Investor Pitch
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc. (NASDAQ: GMGI) CEO to Present at the Upcoming 17th Annual LD Micro Main Event
- SportLync Inc. - SportLync Outlines 2025 Roadmap, with Expanded Sports Offerings and Enhanced User Experiences
- Greenwave Technology Solutions Inc. (NASDAQ: GWAV) - TechMediaBreaks - Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Sees Margin Growth as Scrap Steel Prices Surge
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) to Participate at Upcoming LD Micro Main Event XVII
- HeartBeam Inc. (NASDAQ: BEAT) - BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
- HealthLynked Corp. (OTCQB: HLYK) - BioMedNewsBreaks - HealthLynked Corp. (HLYK) Launches Upgrade to Empower Patients, Drive Better Outcomes
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Featured in Latest Episode of MarketGems Podcast
- Horizon Fintex | Upstream - InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Launches Rebrand Featuring New Name, New Look, New Packaging
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp. (BLQC) Completes 'Key Steps' in Long-Term Vision to Strengthen Position as an Innovator in Healthcare Solutions
- Kairos Pharma Ltd. (NYSE American: KAPA) - BioMedNewsBreaks - Kairos Pharma Ltd. (NYSE American: KAPA) to Participate in D. Boral Capital Global Conference on May 14
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Grows Q1 Revenue 29% and Narrows Losses Ahead of Investor Showcase
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Announces Entry into Common Stock Purchase Agreements with Gross Proceeds of $750K
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Present 'Important' Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer's Disease Conference
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - Why Trump May Be Unlikely to Stop Public EV Charger Construction
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc.'s (NASDAQ: LTRY) Sports.com Achieves Major Milestone in Its Global Expansion
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Record Transaction Growth, No. 1 Ranking on Lightning Terminal
- Massimo Group (NASDAQ: MAMO) - The Slate Truck Could Usher in New Era for EVs
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Targets Gold Growth with Fox Complex Expansion, Reports Q1 Results
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- NanoViricides Inc. (NYSE American: NNVC) - InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials
- Newton Golf Company Inc. (NASDAQ: NWTG) - TinyGemsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Reports 246% Revenue Growth and Expanding Tour Adoption in Q1
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - BioMedNewsBreaks - NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds
- Nightfood Holdings Inc. (OTCQB: NGTF) - TechMediaBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney's Cotino Project
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Poised to Capitalize on Copper Demand Surge Driven by AI-Powered Data Centers
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Oragenics Inc. (NYSE American: OGEN) - InvestorNewsBreaks - Oragenics Inc. (NYSE American: OGEN) Secures Australian Approval to Launch Phase II Concussion Trial
- Mullen Automotive Inc. (NASDAQ: MULN) - Foxtron Announces Project to Develop, Make EVs for Mitsubishi
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Leads the Charge in AI-Driven Marketing with Proprietary Platform
- PaxMedica Inc. (NASDAQ: PXMD) - Kids with Autism are Less Prone to Severe Injuries Compared to Those with ADHD
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself for Growth Amid Palladium Market Dynamics
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 17% Working Interest Increase in Its Core Heavy Oil Properties
- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) - InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Dosing in Key Toxicity Studies for MS Drug Candidate
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - IEA Review: 2024 Electricity Demand Surge Boosted Both Fossil Fuels and Renewables
- Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) - InvestorNewsBreaks - Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Highlights Exploration Strategy and Growth Potential on The Bell2Bell Podcast
- G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) - InvestorNewsBreaks - G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Delivers Free Cash Flow and $24.4M Q1 Profit, Advances Oko West
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc.'s (NASDAQ: NITO) (FSE: 80W) Subsidiary Enters LOI with Ethiopian Federal Agency to Support Transition to Sustainable Farming Practices
- Software Effective Solutions Corp. (OTC: SFWJ) - InvestorNewsBreaks - Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) Cancels and Swaps Over 88M Shares to Reduce Outstanding Share Count
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - GreenEnergyBreaks - SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants
- SUIC Worldwide Holdings Ltd. (OTC: SUIC) - InvestorNewsBreaks - SUIC Worldwide Holdings Ltd. (SUIC) Names Seasoned Veteran as Newest Director
- SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) to Attend Two Upcoming Industry Events
- SOBRsafe Inc. (NASDAQ: SOBR) - InvestorNewsBreaks - SOBRsafe Inc. (NASDAQ: SOBR) Appoints Kris Pederson to Board, Adds Scientific Advisor to Advance Tech and Governance
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group, Inc. (NYSE American: SBEV) Revises Terms for Western Son Vodka Acquisition
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (NYSE American: SLI) Advances Southwest Arkansas Lithium Project with $225M DOE Grant, Regulatory Milestones
- Starco Brands Inc. (OTCQB: STCB) - InvestorNewsBreaks - Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils Market's Most Efficient, Powerful Inboard Electric Motor System
- SenesTech Inc. (NASDAQ: SNES) - InvestorNewsBreaks - SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - TechMediaBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Expands Into Africa with Focus on Cybersecurity for Government and Enterprise Clients
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - InvestorNewsBreaks - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Names Seasoned Veteran as New Director
- Thumzup Media Corp. (NASDAQ: TZUP) - UN Study Suggests AI Could Boost Human Development
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) - InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
- Torr Metals Inc. (TSX.V: TMET) - Gold Ticks Up as Dollar Loses Steam
- TransCode Therapeutics Inc. (NASDAQ: RNAZ) - InvestorNewsBreaks - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances RNA Cancer Therapy as 15 Patients Dosed in Phase 1a Trial
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - MiningNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Secures Debentureholder Approval for Debt Settlement and Extension
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shareholders Approve Key Proposals at Extraordinary General Meeting
- Uranium Energy Corp. (NYSE American: UEC) - BillionDollarBreaks - Uranium Energy Corp. (NYSE American: UEC) Partners with Radiant on U.S. Nuclear Microreactor Fuel Supply
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
- Datavault AI Inc. (NASDAQ: DVLT) - InvestorNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) Reaffirms $50M 2026 Revenue Target Ahead of CSI Acquisition Close
- Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) - InvestorNewsBreaks - Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Reports Record Revenue and Raises Dividend in Strong Q1 2025
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
- Adageis - InvestorNewsBreaks – Adageis’ Fintech Platform Drives Smarter, More Profitable Healthcare
- Aditxt Inc. (NASDAQ: ADTX) - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics
- Amesite Inc. (NASDAQ: AMST) - Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - Appia Announces That Stephen Burega is Leaving the Company
- Annovis Bio Inc. (NYSE: ANVS) - InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Appoints Hui Liu as Director of Biostatistics
- Astiva Health - UnitedHealth Records Lower Revenue as Medical Advantage Use Grows
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Arizona Metals Intersects 34.8 m @ 11.3 g/t AuEq in Kay2 Zone
- Astrotech Corp. (NASDAQ: ASTC) - 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Scrap Copper to Start Moving After Trump Declared Truce with China
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) - Battery Mineral Resources Announces Receipt of Second Payment and Closing of Previously Announced Royalty Financing with Electric Royalties
- Bebuzee Inc. (OTC: BBUZ) - InvestorNewsBreaks - Bebuzee Inc. (BBUZ) Revolutionizes Content Monetization with Creator-First Super App
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - BioMedNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain in 2024, Driven by Loan-to-Equity Conversion
- Bravo Multinational Inc. (OTC: BRVO) - InvestorNewsBreaks - Bravo Multinational Inc. (OTC: BRVO) Unveils First Charitable Mobile Service
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology 2024 Financial Results Report: Total Assets Surge by 53%
- Btab Ecommerce Group Inc. (OTC: BBTT) - Integrated Wellness Acquisition Corp. and Btab Ecommerce Group, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
- Brera Holdings PLC (NASDAQ: BREA) - Brera Holdings PLC (NASDAQ: BREA) to Pilot 'PLAY LEAP' Digital Fan Engagement Platform with Juve Stabia
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - Canada Nickel Secures US$20 Million Bridge Loan Facilitated by BT Capital and Provides Corporate Update
- CISO Global, Inc. (NASDAQ: CISO) - CISO Global brings AI to $50 Billion Insurance Market with Cyber Assurance Group Strategic Partnership to Deliver Innovative Cyber Technology and Insurance Solutions
- Clene Inc. (NASDAQ: CLNN) - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Reports Q1 Results, Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer
- Correlate Energy Corp. (OTCQB: CIPI) - GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
- Coyuchi Inc. - InvestorNewsBreaks – Coyuchi Inc. Pushing Organic Textile Market Forward Through Its Circular Initiatives
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. Eyes Increase in Stock Price
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Taps Thermo Fisher for Phase 3 and Commercial Production of CYB003
- DarioHealth Corp. (NASDAQ: DRIO) - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
- Diamond Lake Minerals Inc. (OTC: DLMI) - Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
- Data443 Risk Mitigation Inc. (OTC: ATDS) - Data443 Completes Operational Expense Rationalization
- D-Wave Quantum Inc. (NYSE: QBTS) - Further US Chip Export Restrictions Pose More Challenges for Nvidia
- ECGI Holdings Inc. (OTC: ECGI) - InvestorNewsBreaks - ECGI Holdings Inc. (ECGI) Confident Its New Allon Apparel Line Will Set 'New Benchmark' in Luxury Market
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Eloro Resources Announces Closing of $2.5 Million Non-Brokered Private Placement
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Engages Norda Stelo for Gap Analysis at Lac Pelletier, Eyes Near-Term Production
- Energy and Water Development Corp. (OTCQB: EAWD) - Data Officers and the Crucial Role They Play in ESG Accountability
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Posts $26 Million Q1 Loss, Increases 2025 Uranium Production Forecast
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - EverGen Infrastructure Reports Q4 & Year End 2024 Results
- ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Draws Additional Experience to Board Amid Ramp-up to Production
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - Exro Technologies Responds to Market Activity
- FingerMotion Inc. (NASDAQ: FNGR) - TechMediaBreaks - FingerMotion Inc. (NASDAQ: FNGR) Expands to Indonesia with AI Insurance Platform Through Mach Wireless Deal
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - InvestorNewsBreaks - First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - MiningNewsBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Upsizes Private Placement to C$1.5 Million on Strong Investor Demand
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Posts $26 Million Q1 Loss, Increases 2025 Uranium Production Forecast
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) Announces Proposed $1M Non-Brokered Private Placement
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) - InvestorNewsBreaks - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Completes Geophysical Survey at CLK Uranium Property in Athabasca Basin
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), BuilderX Partner to Integrate Advanced 3D Perception Technology into Heavy Machinery
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Freight Technologies Inc. (NASDAQ: FRGT) - TechMediaBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Moves to Advance Digital Asset Strategy
- Gaxos.ai Inc. (NASDAQ: GXAI) - AINewsBreaks - Gaxos.ai Inc. (NASDAQ: GXAI) Approved for AWS Marketplace Listing, Expanding Reach for Game Developer Platform
- GEMXX Corp. (OTC: GEMZ) - Baker Hughes Says Oil, Gas Rigs in the US Have Reduced Significantly
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) - InvestorNewsBreaks - Global Compliance Applications Corp. (CSE: APP) (OTC: FUAPF) (FSE: 2FA), EMTRI Corp. Scale Services in California's Booming Cannabis Market
- GivBux Inc. (OTC: GBUX) - InvestorNewsBreaks - GivBux Inc. (OTC: GBUX) to Appear on Cheddar TV's 'Go Fund Yourself' for Live Investor Pitch
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc. (NASDAQ: GMGI) CEO to Present at the Upcoming 17th Annual LD Micro Main Event
- SportLync Inc. - SportLync Outlines 2025 Roadmap, with Expanded Sports Offerings and Enhanced User Experiences
- Greenwave Technology Solutions Inc. (NASDAQ: GWAV) - TechMediaBreaks - Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Sees Margin Growth as Scrap Steel Prices Surge
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) to Participate at Upcoming LD Micro Main Event XVII
- HeartBeam Inc. (NASDAQ: BEAT) - BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
- HealthLynked Corp. (OTCQB: HLYK) - BioMedNewsBreaks - HealthLynked Corp. (HLYK) Launches Upgrade to Empower Patients, Drive Better Outcomes
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Featured in Latest Episode of MarketGems Podcast
- Horizon Fintex | Upstream - InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Launches Rebrand Featuring New Name, New Look, New Packaging
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp. (BLQC) Completes 'Key Steps' in Long-Term Vision to Strengthen Position as an Innovator in Healthcare Solutions
- Kairos Pharma Ltd. (NYSE American: KAPA) - BioMedNewsBreaks - Kairos Pharma Ltd. (NYSE American: KAPA) to Participate in D. Boral Capital Global Conference on May 14
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Grows Q1 Revenue 29% and Narrows Losses Ahead of Investor Showcase
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Announces Entry into Common Stock Purchase Agreements with Gross Proceeds of $750K
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Present 'Important' Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer's Disease Conference
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - Why Trump May Be Unlikely to Stop Public EV Charger Construction
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc.'s (NASDAQ: LTRY) Sports.com Achieves Major Milestone in Its Global Expansion
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Record Transaction Growth, No. 1 Ranking on Lightning Terminal
- Massimo Group (NASDAQ: MAMO) - The Slate Truck Could Usher in New Era for EVs
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Targets Gold Growth with Fox Complex Expansion, Reports Q1 Results
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- NanoViricides Inc. (NYSE American: NNVC) - InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials
- Newton Golf Company Inc. (NASDAQ: NWTG) - TinyGemsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Reports 246% Revenue Growth and Expanding Tour Adoption in Q1
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - BioMedNewsBreaks - NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds
- Nightfood Holdings Inc. (OTCQB: NGTF) - TechMediaBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney's Cotino Project
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Poised to Capitalize on Copper Demand Surge Driven by AI-Powered Data Centers
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Oragenics Inc. (NYSE American: OGEN) - InvestorNewsBreaks - Oragenics Inc. (NYSE American: OGEN) Secures Australian Approval to Launch Phase II Concussion Trial
- Mullen Automotive Inc. (NASDAQ: MULN) - Foxtron Announces Project to Develop, Make EVs for Mitsubishi
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Leads the Charge in AI-Driven Marketing with Proprietary Platform
- PaxMedica Inc. (NASDAQ: PXMD) - Kids with Autism are Less Prone to Severe Injuries Compared to Those with ADHD
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself for Growth Amid Palladium Market Dynamics
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 17% Working Interest Increase in Its Core Heavy Oil Properties
- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) - InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Dosing in Key Toxicity Studies for MS Drug Candidate
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - IEA Review: 2024 Electricity Demand Surge Boosted Both Fossil Fuels and Renewables
- Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) - InvestorNewsBreaks - Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Highlights Exploration Strategy and Growth Potential on The Bell2Bell Podcast
- G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) - InvestorNewsBreaks - G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Delivers Free Cash Flow and $24.4M Q1 Profit, Advances Oko West
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc.'s (NASDAQ: NITO) (FSE: 80W) Subsidiary Enters LOI with Ethiopian Federal Agency to Support Transition to Sustainable Farming Practices
- Software Effective Solutions Corp. (OTC: SFWJ) - InvestorNewsBreaks - Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) Cancels and Swaps Over 88M Shares to Reduce Outstanding Share Count
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - GreenEnergyBreaks - SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants
- SUIC Worldwide Holdings Ltd. (OTC: SUIC) - InvestorNewsBreaks - SUIC Worldwide Holdings Ltd. (SUIC) Names Seasoned Veteran as Newest Director
- SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) to Attend Two Upcoming Industry Events
- SOBRsafe Inc. (NASDAQ: SOBR) - InvestorNewsBreaks - SOBRsafe Inc. (NASDAQ: SOBR) Appoints Kris Pederson to Board, Adds Scientific Advisor to Advance Tech and Governance
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group, Inc. (NYSE American: SBEV) Revises Terms for Western Son Vodka Acquisition
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (NYSE American: SLI) Advances Southwest Arkansas Lithium Project with $225M DOE Grant, Regulatory Milestones
- Starco Brands Inc. (OTCQB: STCB) - InvestorNewsBreaks - Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils Market's Most Efficient, Powerful Inboard Electric Motor System
- SenesTech Inc. (NASDAQ: SNES) - InvestorNewsBreaks - SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - TechMediaBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Expands Into Africa with Focus on Cybersecurity for Government and Enterprise Clients
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - InvestorNewsBreaks - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Names Seasoned Veteran as New Director
- Thumzup Media Corp. (NASDAQ: TZUP) - UN Study Suggests AI Could Boost Human Development
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) - InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
- Torr Metals Inc. (TSX.V: TMET) - Gold Ticks Up as Dollar Loses Steam
- TransCode Therapeutics Inc. (NASDAQ: RNAZ) - InvestorNewsBreaks - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances RNA Cancer Therapy as 15 Patients Dosed in Phase 1a Trial
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - MiningNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Secures Debentureholder Approval for Debt Settlement and Extension
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shareholders Approve Key Proposals at Extraordinary General Meeting
- Uranium Energy Corp. (NYSE American: UEC) - BillionDollarBreaks - Uranium Energy Corp. (NYSE American: UEC) Partners with Radiant on U.S. Nuclear Microreactor Fuel Supply
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
- Datavault AI Inc. (NASDAQ: DVLT) - InvestorNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) Reaffirms $50M 2026 Revenue Target Ahead of CSI Acquisition Close
- Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) - InvestorNewsBreaks - Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Reports Record Revenue and Raises Dividend in Strong Q1 2025
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.